Buy CELG on a Pullback or a Breakout

By
A A A

Celgene Corp. (NASDAQ: CELG ) - A stock that should be on the list of Nasdaq bargains is Celgene. The company reported second-quarter earnings yesterday that showed an increase of 78% over the like period last year and beat analysts' expectations.

Celgene is a growth stock that increased its revenues by 38% in Q2. Its impressive performance was led by its cancer products Revlimid and Vidaza. And the company has a number of other products in the pipeline awaiting FDA approval.

Yesterday, Celgene upped its guidance for this year to $3.45-$3.55 from $3.35-$3.40. Combined analysts' target for the stock is mid-$70s.

Technically, CELG appears to be breaking from a broad top that extends from early last year. A breakout through the resistance line at $62 yields a target of $74. Buy on a continuation of the breakout or a pullback to support at $58.

Trade of the Day - Celgene Corp. (NASDAQ:CELG)

Trade of the Day Chart Key

Ask Sam on Facebook



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Investing Ideas , Stocks

Referenced Stocks: CELG

Sam Collins

Sam Collins

More from Sam Collins:

Related Videos

The Pumpkin Carvers
The Pumpkin Carvers                 

Stocks

Referenced

100%

Most Active by Volume

88,066,694
  • $97.19 ▲ 2.61%
58,241,731
  • $71.29 ▲ 2.92%
51,058,864
  • $44.87 ▲ 0.09%
48,927,829
  • $28.75 ▲ 0.81%
46,551,917
    $15.52 unch
40,249,498
  • $3.46 ▼ 0.57%
38,633,031
  • $22.43 ▼ 9.63%
38,240,825
  • $34.71 ▲ 3.30%
As of 7/23/2014, 04:04 PM